Merus (NASDAQ:MRUS) Given Buy Rating at Guggenheim

Guggenheim reaffirmed their buy rating on shares of Merus (NASDAQ:MRUS – Free Report) in a research note published on Friday,Benzinga reports. They currently have a $109.00 price target on the biotechnology company’s stock. Several other research analysts have also weighed in on MRUS. Bank of America lowered their price objective on Merus from $73.00 to […]

Mar 29, 2025 - 08:53

Guggenheim reaffirmed their buy rating on shares of Merus (NASDAQ:MRUS – Free Report) in a research note published on Friday,Benzinga reports. They currently have a $109.00 price target on the biotechnology company’s stock. Several other research analysts have also weighed in on MRUS. Bank of America lowered their price objective on Merus from $73.00 to […]